Stock screenerAll disclosures →
EDGAR →
PCRX
Conviction 43HealthcareScan · Mon, Aug 10, 2026PCRX$24.44-2.32%
ResistanceSupportVol 14Insider sellVol MA14 752.07K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price24.44
Change-2.32%
Gap-0.56%
Rel volume1.14×
Avg volume688.17K
Avg $ vol17.82M
SMA 2025.88
SMA 5024.69
SMA 20023.57
Price vs 50-0.99%
Price vs 200+3.68%
MA stackmixed
50/200 cross—
Supertrendup · 24.32
RSI (14)42
MACD hist-0.27
MACD crossbear · 3d
Stoch %K / %D7 / 23
ADX (14)29
+DI / −DI16 / 23
RSI divergence—
MACD divergenceBearish
ATR %+4.34%
ADR %3.80%
52w high27.62
52w low19.16
From 52w high-11.51%
Above 52w low+27.56%
New 52w highNo
SqueezeOff
Bollinger width12.25%
%B0.05
Donchian pos6.67%
Donchian high27.66
Donchian low24.21
AVWAP (52w high)25.61
vs AVWAP high-4.56%
AVWAP (52w low)23.28
vs AVWAP low+4.96%
OBV trendFlat
Chaikin MF (20)0.17
Today vs 20d1.14×
Avg vol (14d)752.07K
Avg vol (20d)688.17K
Avg $ vol (20d)17.82M
Market cap974.22M
RS 3m (vs SPY)+0.14%
RS 6m (vs SPY)+8.77%
RS line new highNo
Trend template4/8
Technical rank47.7
1 week-9.21%
1 month-4.08%
3 months+5.57%
6 months+16.38%
1 year+2.82%
YTD-0.08%
P/E138.50
P/B1.45
P/S1.34
P/FCF7.13
EPS0.1600
Div yield—
ROE1.05%
ROA0.57%
Debt/Eq0.54
Current5.04
EV/EBITDA10.27
Gross margin—
Net margin0.97%
Rev growth3.63%
EPS growth107.07%
Price target28.80
Target upside17.84%
Analyst ratingBuy
Institutional122.46%
Ent. value1.13B
Revenue192.4M
Net income4.65M
Gross profit—
Free cash flow136.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees829
ListedThu, Feb 3, 2011
Free float37.93M
Float %93.7%
Short interest6.96M
Days to cover15.8d
Short volume71.3%
Squeeze score84 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.44 vs $0.27
Last surprise+63.0% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank47.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance27.41
Support23.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PCRX
No recent disclosed trades by Congress in PCRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PCRX · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BIGAL MARCELO Director · Common Stock · 2026-06-10 | Grant | 6.41K | — | 2026-06-10 | 2026-06-12 |
BIGAL MARCELO Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 10.89K | — | 2026-06-10 | 2026-06-12 |
WILLIAMS KRISTEN Chief Administrative Officer · Common Stock · 2026-06-04 | Sell | 10.26K | $228K | 2026-06-04 | 2026-06-05 |
SLONIN JONATHAN Chief Medical Officer · Common Stock · 2026-06-03 | Tax | 4.73K | $106K | 2026-06-03 | 2026-06-05 |
WILLIAMS KRISTEN Chief Administrative Officer · Common Stock · 2026-06-03 | Tax | 8.53K | $190K | 2026-06-03 | 2026-06-05 |
RIKER LAUREN Senior Vice President, Finance · Common Stock · 2026-06-03 | Tax | 3.19K | $71K | 2026-06-03 | 2026-06-05 |
Cross Shawn Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-23 | Exercise | 12.94K | $0 | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Common Stock · 2026-04-23 | Sell | 12.94K | $326K | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Common Stock · 2026-04-23 | Exercise | 12.94K | $213K | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-22 | Exercise | 1.5K | $0 | 2026-04-22 | 2026-04-22 |
SEC filings
EDGAR filings in PCRX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.